Skip to content

CEREBAIN BIOTECH CORP.: 10-Q filed 2012-05-15

What CEREBAIN BIOTECH CORP. reported in its quarterly report filed 2012-05-15 (fiscal Q3 2012): 24 published measures, 80 facts as tagged in accession 0001078782-12-001382.

This filing

Form
10-Q (quarterly report)
Filed
2012-05-15
Fiscal period
fiscal Q3 2012
Accession
0001078782-12-001382 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All CEREBAIN BIOTECH CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-03-3184,799USD
At 2011-06-3077,858USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-03-31664,460USD
At 2011-06-30403,049USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-03-31-579,661USD
At 2011-06-30-325,191USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-03-31328USD
At 2011-06-30746USD
At 2011-03-31830USD
At 2010-06-30220USD
At 2010-02-210USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-03-31-139,449USD91
2011-07-01 to 2012-03-31-799,354USD275
2010-02-22 to 2012-03-31-1,304,045USD769
2011-01-01 to 2011-03-31-91,529USD90
2010-07-01 to 2011-03-31-295,730USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-07-01 to 2012-03-31-771,812USD275
2010-02-22 to 2012-03-31-917,795USD769
2010-07-01 to 2011-03-31-131,869USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-07-01 to 2012-03-31779,394USD275
2010-02-22 to 2012-03-31947,134USD769
2010-07-01 to 2011-03-31153,490USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-07-01 to 2012-03-31-8,000USD275
2010-02-22 to 2012-03-31-29,011USD769
2010-07-01 to 2011-03-31-21,011USD274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-01-01 to 2012-03-31-400USD91
2011-07-01 to 2012-03-31-800USD275
2010-02-22 to 2012-03-31-2,600USD769
2011-01-01 to 2011-03-310USD90
2010-07-01 to 2011-03-310USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-03-31-139,049USD91
2011-07-01 to 2012-03-31-798,554USD275
2010-02-22 to 2012-03-31-1,301,445USD769
2011-01-01 to 2011-03-31-91,529USD90
2010-07-01 to 2011-03-31-295,730USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-03-31328USD
At 2011-06-30746USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-03-31664,460USD
At 2011-06-30403,049USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-03-3190,536USD
At 2011-06-307,649USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-01-01 to 2012-03-31139,049USD91
2011-07-01 to 2012-03-31798,554USD275
2010-02-22 to 2012-03-311,301,445USD769
2011-01-01 to 2011-03-3191,529USD90
2010-07-01 to 2011-03-31295,730USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2012-01-01 to 2012-03-31138,836USD91
2011-07-01 to 2012-03-31400,913USD275
2010-02-22 to 2012-03-31903,305USD769
2011-01-01 to 2011-03-3191,315USD90
2010-07-01 to 2011-03-31295,445USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-03-3130,980,001shares
At 2011-06-3029,425,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-03-31693,404USD
At 2011-06-30150,075USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-01-01 to 2012-03-31-139,049USD91
2011-07-01 to 2012-03-31-798,554USD275
2010-02-22 to 2012-03-31-1,301,445USD769
2011-01-01 to 2011-03-31-91,529USD90
2010-07-01 to 2011-03-31-295,730USD274

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-07-01 to 2012-03-31-799,354USD275
2010-02-22 to 2012-03-31-1,304,045USD769
2010-07-01 to 2011-03-31-295,730USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-03-31213USD91
2011-07-01 to 2012-03-31641USD275
2010-02-22 to 2012-03-311,140USD769
2011-01-01 to 2011-03-31214USD90
2010-07-01 to 2011-03-31285USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2011-07-01 to 2012-03-31641USD275
2010-02-22 to 2012-03-311,140USD769
2010-07-01 to 2011-03-31285USD274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2011-07-01 to 2012-03-310USD275
2010-02-22 to 2012-03-310USD769
2010-07-01 to 2011-03-310USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-07-01 to 2012-03-31544,884USD275
2010-02-22 to 2012-03-31707,134USD769
2010-07-01 to 2011-03-31141,000USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-07-01 to 2012-03-3182,887USD275
2010-02-22 to 2012-03-3190,536USD769
2010-07-01 to 2011-03-31816USD274

Inspect the source

Entity
CEREBAIN BIOTECH CORP. / CIK 0001453099
Captured
SEC response SHA-256
9fdf4c3b2bb6536cc10c8e24af596aaa762e0560a25fd29c07e252f58d07262f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001453099.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))